Search results
Myricx Bio gains $114m in Series A round to develop NMTi-ADCs
Pharmaceutical Technology· 3 days agoMyricx Bio CEO Dr Robin Carr stated: “I am truly grateful for the support of our founding investors...
Myricx Bio CEO Dr Robin Carr stated: “I am truly grateful for the support of our founding investors...